|
Volumn 86, Issue 8, 2002, Pages 1238-1242
|
A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site
a a a a a |
Author keywords
Adenocarcinoma; Carcinoma of unknown primary site; MCF
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
MITOMYCIN C;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER PATIENT;
CANCER SURVIVAL;
CLINICAL EXAMINATION;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA AND VOMITING;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
THROMBOSIS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CISPLATIN;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
MITOMYCIN;
NEOPLASMS, UNKNOWN PRIMARY;
SURVIVAL ANALYSIS;
|
EID: 0037156958
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6600258 Document Type: Article |
Times cited : (24)
|
References (29)
|